ID   CDON_RAT                Reviewed;        1256 AA.
AC   O35158;
DT   02-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 2.
DT   02-OCT-2024, entry version 145.
DE   RecName: Full=Cell adhesion molecule-related/down-regulated by oncogenes;
DE   Flags: Precursor;
GN   Name=Cdon; Synonyms=Cdo;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), INDUCTION, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=9214393; DOI=10.1083/jcb.138.1.203;
RA   Kang J.-S., Gao M., Feinleib J.L., Cotter P.D., Guadagno S.N., Krauss R.S.;
RT   "CDO: an oncogene-, serum-, and anchorage-regulated member of the
RT   Ig/fibronectin type III repeat family.";
RL   J. Cell Biol. 138:203-213(1997).
RN   [2]
RP   INTERACTION WITH PTCH1, BOC AND GAS1, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF PRO-686; VAL-777; ILE-787 AND SER-937.
RX   PubMed=21802063; DOI=10.1016/j.ajhg.2011.07.001;
RA   Bae G.U., Domene S., Roessler E., Schachter K., Kang J.S., Muenke M.,
RA   Krauss R.S.;
RT   "Mutations in CDON, encoding a hedgehog receptor, result in
RT   holoprosencephaly and defective interactions with other hedgehog
RT   receptors.";
RL   Am. J. Hum. Genet. 89:231-240(2011).
CC   -!- FUNCTION: Component of a cell-surface receptor complex that mediates
CC       cell-cell interactions between muscle precursor cells. Promotes
CC       differentiation of myogenic cells (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Part of a complex that contains BOC, CDON, NEO1, cadherins and
CC       CTNNB1. Interacts with NTN3. Interacts with DHH, IHH and SHH (By
CC       similarity). Interacts with PTCH1. Interacts with GAS1. {ECO:0000250,
CC       ECO:0000269|PubMed:21802063}.
CC   -!- INTERACTION:
CC       O35158; P00519: ABL1; Xeno; NbExp=4; IntAct=EBI-7016767, EBI-375543;
CC       O35158; Q9BWV1: BOC; Xeno; NbExp=2; IntAct=EBI-7016767, EBI-718555;
CC       O35158; Q01721: Gas1; Xeno; NbExp=4; IntAct=EBI-7016767, EBI-15729104;
CC       O35158; Q13635: PTCH1; Xeno; NbExp=2; IntAct=EBI-7016767, EBI-8775406;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:21802063,
CC       ECO:0000269|PubMed:9214393}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:21802063, ECO:0000269|PubMed:9214393}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O35158-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O35158-2; Sequence=VSP_018202;
CC   -!- TISSUE SPECIFICITY: Detected at low levels in stomach, spleen, brain,
CC       large intestine and lung. {ECO:0000269|PubMed:9214393}.
CC   -!- INDUCTION: Down-regulated in actively dividing cells. Not detectable in
CC       suspension cultures. Accumulates only in cells that are attached to a
CC       solid substrate (in vitro). {ECO:0000269|PubMed:9214393}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:9214393}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF004840; AAC34735.1; -; mRNA.
DR   PIR; T03096; T03096.
DR   RefSeq; NP_059054.1; NM_017358.1.
DR   AlphaFoldDB; O35158; -.
DR   SMR; O35158; -.
DR   BioGRID; 248437; 2.
DR   IntAct; O35158; 4.
DR   MINT; O35158; -.
DR   STRING; 10116.ENSRNOP00000016247; -.
DR   GlyCosmos; O35158; 9 sites, No reported glycans.
DR   GlyGen; O35158; 9 sites.
DR   PhosphoSitePlus; O35158; -.
DR   PaxDb; 10116-ENSRNOP00000016247; -.
DR   GeneID; 50938; -.
DR   KEGG; rno:50938; -.
DR   UCSC; RGD:708433; rat. [O35158-1]
DR   AGR; RGD:708433; -.
DR   CTD; 50937; -.
DR   RGD; 708433; Cdon.
DR   eggNOG; ENOG502QT4P; Eukaryota.
DR   InParanoid; O35158; -.
DR   OrthoDB; 3138076at2759; -.
DR   PhylomeDB; O35158; -.
DR   Reactome; R-RNO-525793; Myogenesis.
DR   Reactome; R-RNO-5632681; Ligand-receptor interactions.
DR   PRO; PR:O35158; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; IMP:RGD.
DR   GO; GO:0001708; P:cell fate specification; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0021987; P:cerebral cortex development; ISO:RGD.
DR   GO; GO:0010172; P:embryonic body morphogenesis; ISO:RGD.
DR   GO; GO:0048598; P:embryonic morphogenesis; ISO:RGD.
DR   GO; GO:0060059; P:embryonic retina morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0002088; P:lens development in camera-type eye; ISO:RGD.
DR   GO; GO:0007520; P:myoblast fusion; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0061351; P:neural precursor cell proliferation; ISO:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; ISO:RGD.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0051057; P:positive regulation of small GTPase mediated signal transduction; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0045664; P:regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0014816; P:skeletal muscle satellite cell differentiation; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; IDA:MGI.
DR   GO; GO:0051146; P:striated muscle cell differentiation; ISO:RGD.
DR   CDD; cd00063; FN3; 3.
DR   CDD; cd00096; Ig; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 8.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR44170:SF30; FIBRONECTIN TYPE-III DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR44170; PROTEIN SIDEKICK; 1.
DR   Pfam; PF00041; fn3; 3.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13927; Ig_3; 3.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 5.
DR   SMART; SM00408; IGc2; 4.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   SUPFAM; SSF48726; Immunoglobulin; 5.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Cell membrane; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Membrane; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..1256
FT                   /note="Cell adhesion molecule-related/down-regulated by
FT                   oncogenes"
FT                   /id="PRO_0000234056"
FT   TOPO_DOM        25..963
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        964..984
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        985..1256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..113
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          119..203
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          224..305
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          310..396
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          405..516
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          573..674
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          720..815
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          823..923
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          522..550
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          671..696
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          929..952
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1174..1212
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1231..1256
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        671..685
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        935..952
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1176..1194
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1195..1211
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        99
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        179
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        286
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        293
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        294
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        342
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        427
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        570
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        870
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..96
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        140..190
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        242..289
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        333..380
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        426..500
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         400..516
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9214393"
FT                   /id="VSP_018202"
FT   MUTAGEN         686
FT                   /note="P->A: Fails to support induction of the Sonic
FT                   hedgehog/SSH receptors PTCH1 and GLI1. The mutant protein
FT                   retains very little residual activity even during
FT                   overexpression and interacts with SHH, but does not
FT                   interact with PTCH1, BOC, or GAS1."
FT                   /evidence="ECO:0000269|PubMed:21802063"
FT   MUTAGEN         777
FT                   /note="V->E: Fails to support induction of the Sonic
FT                   hedgehog/SSH receptors PTCH1 and GLI1. The mutant protein
FT                   retains some residual activity during overexpression. The
FT                   mutant protein interacts with SHH, but does not interact
FT                   with PTCH1. The mutation protein has a shorted half-life
FT                   compared to wild-type and may have an altered conformation
FT                   resulting in destabilization."
FT                   /evidence="ECO:0000269|PubMed:21802063"
FT   MUTAGEN         787
FT                   /note="I->A: Fails to support induction of the Sonic
FT                   hedgehog/SSH receptors PTCH1 and GLI1. The mutant protein
FT                   retains some residual activity during overexpression. The
FT                   mutant protein interacts with SHH, but does not interact
FT                   with GAS1."
FT                   /evidence="ECO:0000269|PubMed:21802063"
FT   MUTAGEN         937
FT                   /note="S->R: Fails to support induction of the Sonic
FT                   hedgehog/SSH receptors PTCH1 and GLI1. The mutant protein
FT                   retains some residual activity during overexpression. The
FT                   mutant protein interacts with SHH, but does not interact
FT                   with PTCH1 or GAS1. The mutation protein has a shorted
FT                   half-life compared to wild-type and may have an altered
FT                   conformation resulting in destabilization."
FT                   /evidence="ECO:0000269|PubMed:21802063"
SQ   SEQUENCE   1256 AA;  136204 MW;  775805754F0C2EA4 CRC64;
     MHPDLGPLWK LLYVLVILCS SVSSDLATYF ISEPLSAVQK LGRPVVLHCS AKPVTARISW
     LHNGKRLDRN TEQIKIHRGT LTILSLNPSL SGCYQCVANN SVGAVVSGPA TVSADALADF
     DSSTMHVITA EKKNTGFIGC RVPESNPKAE VRYKIRGKWL MYSTGNYIIL PSGNLQILNV
     SSKDKGSYKC AAYNPVTSEL KVEPAGRKLL VSRPSSDGFH ILHPALSQAL AVLPHSPVTL
     ECVVSGVPAS QVYWLKDGQD CLSGSNWRRL YSHLATASID PADSGNYSCV VGNNSSGDVK
     HVTYTVNVLE HASISKGLHD QKVSLGATVR FTCEVHGNPA PNRTWFHNAQ PIRPSSRHLT
     EGSVLKITGV IMEDSGLYQC MADNGIGFMQ STGRLQIEQD SGQRPVIVTA PANVEVTDGD
     FVTLSCNATG EPVPVIHWYG RHGLITSHPS QVLRSKSRKS HLFRPGDLDP EPVYLIMSQA
     GSSSLSIQAV TREHAGKYTC EAVNKHGSTQ SEAFLTVVPF ETNTKAEPVT PSEASQNDER
     DPRDGSESGL LNLFPVKVHS GGVELPAEKN ASVPDAPNIL SPPQTHMPDT YTLVWRTGRD
     GGMPINAYFV KYRKLDDGSG AVGSWHTVRV PGSESELHLT ELEPSSLYEV LMVARSAVGE
     GQPAMLTFRT SKEKMASSKN TQASFPPVGI PKRPVTSEAS NSNFGVVLTD SSRHSGVPEA
     PDRPTISMAS ETSVYVTWIP RANGGSPITA FKVEYKRMKS SDWLVAAEDI PPSKLSVEVR
     SLEPGSIYKF RVIVINHYGE SFRSSASRPY QVAGFPNRFS NRPITGPHIA YTEAVSDTQI
     MLKWTYIPSS NNNTPIQGFY IYYRPTDSDN DSDYKRDVVE GSKQWHTIGH LQPETSYDIK
     MQCFNEGGES EFSNVMICET KVKRVPGASE YPMKELSTPP SSSGNGGNVG PATSPARSSD
     MLYLIVGCVL GVMVLILLVF IALCLWKSRQ QSAIQKYDPP GYLYQGSEIN GQMVEYTTLS
     GTARINGSVH GGFLSKGSLS NGCSHLHHKG PNGVNGILNG TINGGLYSAH TSSLTRTCVE
     FEHPHHLVNG GAVYTAVPQM DPLECINCRN CRNNNRCFTK TNSPLPVVPV VASYPQDGLE
     MKPLGVMKFP VCPVSTVPDG GQIPEECLKD SVAPAPTQRT CRQDNTSDIN SDSTEDTAEF
     NRGDSSGHSE AEDKVFSWSP LILSPVLEDC SEKTAWSPPG PPLDGLSVVL QQAQET
//
